Purdue Pharma, Sackler, OxyContin

[somarco]

McKinsey said in a statement on Friday that it's "deeply sorry" for its work for Purdue Pharma.

"We should have appreciated the harm opioids were causing in our society and we should not have undertaken sales and marketing work for Purdue Pharma," the company said. "This terrible public health crisis and our past work for opioid manufacturers will always be a source of profound regret for our firm."

McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia.

apnews.com

 

[BALDELMO]

McKinsey said in a statement on Friday that it's "deeply sorry" for its work for Purdue Pharma.

"We should have appreciated the harm opioids were causing in our society and we should not have undertaken sales and marketing work for Purdue Pharma," the company said. "This terrible public health crisis and our past work for opioid manufacturers will always be a source of profound regret for our firm."

McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia.

apnews.com

These "Masters of the Universe" simply see the $650M as a cost of doing business.

 

[somarco]

"Greed is good" . . . until you get caught

 

[AgentGeneral]

McKinsey said in a statement on Friday that it's "deeply sorry" for its work for Purdue Pharma.

"We should have appreciated the harm opioids were causing in our society and we should not have undertaken sales and marketing work for Purdue Pharma," the company said. "This terrible public health crisis and our past work for opioid manufacturers will always be a source of profound regret for our firm."

McKinsey & Company agrees to pay $650M for helping Purdue Pharma boost opioid sales

McKinsey & Company consulting firm has agreed to pay $650 million to settle a federal investigation into its work for opioids manufacturer Purdue Pharma, according to court papers filed in Virginia.

apnews.com

As it should be...many of us have not gone unscathed by the horrific practices of these shit bags.

Sadly that statement probably had to be written by someone else with half a heart. Those blood suckers have zero true empathy.

 

[EckoRomeo]

These were prescription medications, correct? So, an MD had to prescribe these, right? The same MD's that are otherwise infallible and beyond reproach?

If only we had some mechanism in place to prevent the over prescribing of the drugs.

 

[annon123]

These were prescription medications, correct? So, an MD had to prescribe these, right? The same MD's that are otherwise infallible and beyond reproach?

If only we had some mechanism in place to prevent the over prescribing of the drugs.

We need a middle ground where they are not over prescribed but that people who actually need that level of pain relief get it. Research has documented that the current restrictions have not cut back on the number of people addicted to these drugs so clearly the solution to the addiction problem is likely not denying people who need pain relief the pain relief they need.

My PCP makes people take a urine screen, where they'd better come up negative, before he prescribes any of those drugs and will only give people 3 days in a row (I think, but am not positive that the max can be written for is 7 days in a row). At least he gives people enough that they can have 24 hours of pain relief rather than only 12 (that is what happened to me after outpatient, but pretty major surgery) so I was in pretty major pain 12 hours each day. I was told to take Tylenol for the other 12 hours.

Another other problem is that especially the younger MD's whose entire training has been when the access to these have been pretty restricted, don't adequately address the patent's level of pain where these drugs are appropriate. As a result they "let" the patent suffer. Military research found that when soldiers were given pain meds immediately in the field rather than after they were evacuated that it cut way down on the number of them who got PTSD. Makes me wonder how many are now getting PTSD due to unremitting pain that isn't dealt with after surgeries, serious accidents, etc.

Research has also documented that far more, for example, cancer patients die in pretty severe pain now rather than back when there wasn't the addiction concerns, as doctors don't prescribe enough pain meds for fear of addiction. Umm they are dying. What difference does it make?

Physical Therapist research has documented that many of their patients sent to PT now aren't given enough pain meds (the same number of days after, for example, a hip replacement) to be able to be able to be pain free enough to actually do what they need to do in PT. That makes no sense either.

I think the problems surrounding this are complex as are likely the solutions.

 

[EckoRomeo]

We need a middle ground where they are not over prescribed but that people who actually need that level of pain relief get it. Research has documented that the current restrictions have not cut back on the number of people addicted to these drugs so clearly the solution to the addiction problem is likely not denying people who need pain relief the pain relief they need.

I wasn't making a statement on the efficacy of any policy. Just pointing out that this was fueled by doctors writing prescriptions with little oversight. Same doctors who claim they don't need anyone second guessing them.